Literature DB >> 21102648

Lorcaserin--not a new weapon in the battle with appetite.

Jason C G Halford1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21102648     DOI： 10.1038/nrendo.2010.193

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  8 in total

Review 1.  Is susceptibility to weight gain characterized by homeostatic or hedonic risk factors for overconsumption?

Authors:  John E Blundell; Graham Finlayson
Journal:  Physiol Behav       Date:  2004-08

2.  Multicenter, placebo-controlled trial of lorcaserin for weight management.

Authors:  Steven R Smith; Neil J Weissman; Christen M Anderson; Matilde Sanchez; Emil Chuang; Scott Stubbe; Harold Bays; William R Shanahan
Journal:  N Engl J Med       Date:  2010-07-15       Impact factor: 91.245

Review 3.  Serotonergic drugs : effects on appetite expression and use for the treatment of obesity.

Authors:  Jason C G Halford; Joanne A Harrold; Emma J Boyland; Clare L Lawton; John E Blundell
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 4.  Overconsumption and obesity: peptides and susceptibility to weight gain.

Authors:  J E Blundell; F Levin; N A King; B Barkeling; T Gustafsson; T Gustafson; P M Hellstrom; J J Holst; E Naslund
Journal:  Regul Pept       Date:  2008-04-01

5.  Psychological effects of dieting.

Authors:  C Warren; P J Cooper
Journal:  Br J Clin Psychol       Date:  1988-09

Review 6.  Who succeeds in maintaining weight loss? A conceptual review of factors associated with weight loss maintenance and weight regain.

Authors:  K Elfhag; S Rössner
Journal:  Obes Rev       Date:  2005-02       Impact factor: 9.213

7.  Meta-analysis: pharmacologic treatment of obesity.

Authors:  Zhaoping Li; Margaret Maglione; Wenli Tu; Walter Mojica; David Arterburn; Lisa R Shugarman; Lara Hilton; Marika Suttorp; Vanessa Solomon; Paul G Shekelle; Sally C Morton
Journal:  Ann Intern Med       Date:  2005-04-05       Impact factor: 25.391

8.  Who will lose weight on sibutramine and orlistat? Psychological correlates for treatment success.

Authors:  K Elfhag; N Finer; S Rössner
Journal:  Diabetes Obes Metab       Date:  2007-06-26       Impact factor: 6.577
  8 in total
  3 in total

1.  Effects of liraglutide and sibutramine on food intake, palatability, body weight and glucose tolerance in the gubra DIO-rats.

Authors:  Gitte Hansen; Jacob Jelsing; Niels Vrang
Journal:  Acta Pharmacol Sin       Date:  2012-02       Impact factor: 6.150

2.  Lorcaserin: A novel antiobesity drug.

Authors:  Dick B S Brashier; A K Sharma; Navdeep Dahiya; S K Singh; Anjan Khadka
Journal:  J Pharmacol Pharmacother       Date:  2014-04

Review 3.  Serotonergic anti-obesity agents: past experience and future prospects.

Authors:  Jason C G Halford; Emma J Boyland; Clare L Lawton; John E Blundell; Joanne A Harrold
Journal:  Drugs       Date:  2011-12-03       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.